triphenyltetrazolium has been researched along with candesartan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamai, M; Horiuchi, M; Ide, A; Iwai, M; Mogi, M; Tomochika, H; Tomono, Y | 1 |
| Hanif, K; Sharma, G; Singh, N | 1 |
2 other study(ies) available for triphenyltetrazolium and candesartan
| Article | Year |
|---|---|
Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Brain; Brain Ischemia; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Enalapril; Histocompatibility Antigens; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Superoxides; Tetrazoles; Tetrazolium Salts | 2006 |
A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Brain; Brain Edema; Coloring Agents; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; Isoquinolines; Male; Neuroprotective Agents; Neuropsychological Tests; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats, Sprague-Dawley; Reactive Oxygen Species; Tetrazoles; Tetrazolium Salts | 2014 |